alpha-2 adrenergic agonists | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

69,432 results for “alpha-2 adrenergic agonists”

Two Major NIH Grants Totaling $7.3 Million Fund Groundbreaking ADHD Medication Research

FDA Approves Ryzumvi for Treating Drug-Induced Mydriasis

CuraSen Launches Phase 1 Trial of CuraAX for Neurogenic Orthostatic Hypotension and Cognitive Impairment

CuraSen Therapeutics Initiates Phase IIa Trial for Neurogenic Orthostatic Hypotension Treatment

GLP-1 Receptor Agonists Linked to Lower Tuberculosis Risk in Type 2 Diabetes

Atrogi Doses First Patients in Phase 1 Trial of Exercise-Mimicking Drug ATR-258

GLP-1 Agonists Show Significant Benefits for Kidney Transplant Recipients with Type 2 Diabetes

GLP-1 Receptor Agonists Show Survival Benefit in Cancer Patients with Type 2 Diabetes

Real-world Weight Loss Effectiveness of GLP-1 Agonists in Type 2 Diabetes Patients

Meta-Analysis Shows GLP-1 Receptor Agonists Effective for Pediatric Obesity and Type 2 Diabetes

Page 1 of 1481